128 related articles for article (PubMed ID: 30276823)
1. Involvement of neutrophils in Chagas disease pathology.
de Andrade MF; de Almeida VD; de Souza LMS; Paiva DCC; Andrade CM; de Medeiros Fernandes TAA
Parasite Immunol; 2018 Dec; 40(12):e12593. PubMed ID: 30276823
[TBL] [Abstract][Full Text] [Related]
2. The importance of apoptosis for immune regulation in Chagas disease.
DosReis GA; Lopes MF
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():259-62. PubMed ID: 19753482
[TBL] [Abstract][Full Text] [Related]
3. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
[TBL] [Abstract][Full Text] [Related]
4. The clinical immunology of human Chagas disease.
Dutra WO; Rocha MO; Teixeira MM
Trends Parasitol; 2005 Dec; 21(12):581-7. PubMed ID: 16236550
[TBL] [Abstract][Full Text] [Related]
5. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology.
Gironès N; Carrasco-Marin E; Cuervo H; Guerrero NA; Sanoja C; John S; Flores-Herráez R; Fernández-Prieto L; Chico-Calero I; Salgado H; Carrión J; Fresno M
Ann N Y Acad Sci; 2007 Jun; 1107():434-44. PubMed ID: 17804572
[TBL] [Abstract][Full Text] [Related]
6. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
[TBL] [Abstract][Full Text] [Related]
7. [Inflammatory response to acute Trypanosoma cruzi infection].
Cardoni RL
Medicina (B Aires); 1997; 57(2):227-34. PubMed ID: 9532835
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?
De Bona E; Lidani KCF; Bavia L; Omidian Z; Gremski LH; Sandri TL; de Messias Reason IJ
Front Immunol; 2018; 9():1842. PubMed ID: 30127792
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory networks in human Chagas disease.
Dutra WO; Menezes CA; Magalhães LM; Gollob KJ
Parasite Immunol; 2014 Aug; 36(8):377-87. PubMed ID: 24611805
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of myocarditis caused by Trypanosoma cruzi.
Esper L; Talvani A; Pimentel P; Teixeira MM; Machado FS
Curr Opin Infect Dis; 2015 Jun; 28(3):246-52. PubMed ID: 25887609
[TBL] [Abstract][Full Text] [Related]
11. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
Brener Z; Gazzinelli RT
Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils from patients with the cardiac clinical form of Chagas disease release less NETs than neutrophils from healthy individuals.
Duarte de Almeida V; da Câmara EBL; Castro MAA; Pimenta SMP; Hernandes BLT; Paiva DCC; Andrade CM; do Nascimento EGC; Fernandes TAAM; Andrade MF
Parasite Immunol; 2021 Apr; 43(4):e12821. PubMed ID: 33449376
[TBL] [Abstract][Full Text] [Related]
13. Use of clomipramine as chemotherapy of the chronic phase of Chagas disease.
Fauro R; Lo Presti S; Bazan C; Baez A; Strauss M; Triquell F; Cremonezzi D; Negrete OS; Willhuber GC; Paglini-Oliva P; Rivarola HW
Parasitology; 2013 Jun; 140(7):917-27. PubMed ID: 23534690
[TBL] [Abstract][Full Text] [Related]
14. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the biological properties of Trypanosoma cruzi I genotypes in a murine experimental model.
Cruz L; Vivas A; Montilla M; Hernández C; Flórez C; Parra E; Ramírez JD
Infect Genet Evol; 2015 Jan; 29():110-7. PubMed ID: 25461848
[TBL] [Abstract][Full Text] [Related]
17. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
18. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
19. Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.
Benatar AF; García GA; Bua J; Cerliani JP; Postan M; Tasso LM; Scaglione J; Stupirski JC; Toscano MA; Rabinovich GA; Gómez KA
PLoS Negl Trop Dis; 2015; 9(10):e0004148. PubMed ID: 26451839
[TBL] [Abstract][Full Text] [Related]
20. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.
DosReis GA
Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
